TCI Wealth Advisors’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
ISL
PA
NHAS
BTW
TCI Wealth Advisors's CORT Position: Q2 2023 in Review
TCI Wealth Advisors sold out of Corcept Therapeutics (CORT) in Q2 2023, closing a stake of 710 shares — an estimated $15.4K sold.
TCI Wealth Advisors first reported a position in CORT in Q1 2017 and held it in 25 quarters. The position peaked at $15.4K in Q1 2023. 224 funds tracked by Wall St. Rank hold CORT as of Q2 2023.
- TCI Wealth Advisors reported no remaining Corcept Therapeutics position as of Q2 2023 after selling out during the quarter.
- TCI Wealth Advisors sold 710 Corcept Therapeutics shares in Q2 2023, an estimated $15.4K.
- TCI Wealth Advisors first reported a position in Corcept Therapeutics in Q1 2017 and held it in 25 quarters.
- TCI Wealth Advisors's Corcept Therapeutics position peaked at $15.4K in Q1 2023.
- 224 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2023.
Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.